The management of pain from collapse of osteoporotic vertebrae with continuous intrathecal morphine infusion

Neuromodulation

Volumn 10, Issue 2, 2007, Pages 167-176

  Saltari, Maria Rita ^a   Shaladi, Alì ^a   Piva, Bruno ^a   Gilli, Giuseppe ^b   Tartari, Stefano ^c   Dall'Ara, Roberto ^d   Bevilacqua, Marzio ^e   Micheletto, Giuseppe ^f  

^a Ospedale S Maria della Misericordia   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c Hospital of the Delta   (Italy)

^d Hospital Mater Salutes   (Italy)

^e Ospedale Umberto I   (Italy)

^f Hospital of Dolo   (Italy)

Author keywords

Continuous intrathecal morphine infusion; Osteoporosis; Vertebral fracture

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CODEINE; FENTANYL; KETOROLAC; MORPHINE; OPIATE; PARACETAMOL; TRAMADOL;

AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; FEMALE; HEALTH STATUS; HOUSEHOLD; HUMAN; LOADING DRUG DOSE; MALE; MINIPUMP; MOBILIZATION; NAUSEA; OSTEOPOROSIS; PAIN ASSESSMENT; PRURITUS; QUALITY OF LIFE; SCREENING TEST; SOMNOLENCE; URINE RETENTION; VERTEBRA FRACTURE; VISUAL ANALOG SCALE; VOMITING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

EID: 33947631447     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2007.00106.x     Document Type: Article

References (70)

1. Consensus Development Conference. Diagnosis, prophilaxis and treatment of osteoporosis. Am J Med 1993;94:646-650.
2. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series Report 843. Geneva, Switzerland: WHO, 1994.
3. Orwoll ES, Klien RF. Osteoporosis in men. Endocr Rev 1995;16:87-116.
4. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 1997;103:3S-8S.
5. Wu F et al. Fractures between the age of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med 2002;162:33-36.
6. Ross PD. Clinical consequences of vertebral fractures. Am J Med 1997;103 (Suppl.):305-435.
7. Melton LJ, Kan SH, Frye MA, Wahner HW. Epidemiology of vertebral fractures in Women. Am J Epidemiol 1989;129:1000-1011.
8. Cummings SR, Tabor HK. The epidemiology of vertebral fractures. In: Genant HK, Jergas M, van Kuijk C, eds. Vertebral fracture in osteoporosis. San Francisco, CA: Radiology Research and Education Foundation, 1995:3-14.
9. st International Congress on osteoporosis in male-Genova 2003.
10. Adami S, Glatt D, Rossini M. The radiological assessment of vertebral osteoporosis. Bone 1992;13:33-36.
11. Cooper C. Epidemiology of vertebral fractures in Western populations. In: Cooper C, Reeve J, eds. Spine: state of the art reviews: vertebral osteoporosis, vol. 8. Philadelphia, PA: Hanley and Belfus, 1994:1-12.
12. Terrence H, Diamond MD, Bernard Champion MD. Management of acute osteoporotic vertebral fractures: a nonrandomised trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med 2003;114:257-265.
13. Ross PD, Davis JW. Pre-existing fractures and bone mass predict vertebral fracture incidence. Ann Intern Med 1991;114:919-923.
14. Klozbecher CM, Ross PD, Landsmen PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-739.
15. Leidig G, Minne HW, Sauer P et al. A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner 1990;8:217-229.
16. Young MH. Long-term consequences of stabile fractures of the thoracic and lumbar vertebral bodies. J Bone Joint Surg Br 1973;55:295-300.
17. Lukert BP. Vertebral compression fractures. How to manage pain, avoid disability. Geriatrics 1994;49:22-26.
18. Leidig-Bruckner G, Minne HW, Schlaich C et al. Clinical grading of spinal osteoporosis: QOL components and spinal deformity in women with chronic low back pain and with vertebral osteoporosis. J Bone Miner Res 1997;12:663-675.
19. Krane SM, Holick MF. Metabolic bone disease. In: Fauci AS, Braunwald E, Isselbcher KJ et al., eds. Harrisonís Principles of Internal Medicine, International, 14th ed. New York: McGraw-Hill, 1998:2247-2259.
20. Ringe JD. Too many osteoporosis patients are undertreated with analgesics. Chronic pain promotes bone loss. MMW Fortschr Med 2003;145:43-45.
21. Naumann C, Erdine S, Koulousakis A, Van Buyten J-P, Schuchard M. Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations and management. Neuromodulation 1999;2:92-107.
22. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997;70:3-14.
23. Adams PF, Barnes PM. Summary health statistics for the U.S. population: National Health Interview Survey, 2004. Vital Health Stat 2006 Aug;10:1-104.
24. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-infiammatory drugs. N Engl J Med 1999;340:1888-1889.
25. Silverman SL, Azria M. The analgesic role of calcitonin following osteoporotic fractures. Osteoporos Int 2002;13:858-867.
26. Ringe JD, Faber H, Bock O et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int 2002;22:199-203.
27. Scott-Huskisson EC. Graphic representation of pain. Pain 1967;2:175-184.
28. Lips P, Cooper D, Agnusdei F et al. Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporos Int 1999;10:150-160.
29. Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17:505S-511S.
30. Follet KA, Hiltchon PW. Response of intractable pain to continuos intrathecal morphine. Pain 1992;49:21-25.
31. Anderson CA, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-301.
32. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage 1996;11:333-352.
33. Krames ES. Implantable devices for pain control: spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 2002;16:619-649.
34. Hassenbusch SJ, Garber J, Buchser E, Du Pen S, Nitescu P. Alternative intrathecal agents for the treatment of pain. Neuromodulation 1999;2:85-91.
35. Chesunt CH, Rosen CJ. Reconsidering the effect of antiresorptive therapies in reducing osteoporotic fracture. Bone Miner Res 2001;16:2163-2172.
36. Ringe JD. Pathogenese der postmenopausalen osteoporose. Ther Umsch 1994;51:729-736.
37. Riggs BL, Melton JI. Involutional osteoporosis. N Engl J Med 1986;314:1676-1686.
38. Ringe JD. Osteoporose: postmenopausale osteoporose, senile osteoporose, sekundare osteoporose, osteoporose des mannes. Stuttgart, Germany: Georg Thieme Verlag, 1995.
39. Oleksik A, Lips P, Dawson A et al. Health-related QOL in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 2000;15:1384-1392.
40. Greene GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fractures in women: The Rancho Bernardo Study. J Am Geriatr Soc 1995;43:955-961.
41. Lindsay R, Silverman SL, Copper C. Risk of new vertebral fracture in the year following a fracture. J Am Med Assoc 2001;285:320-323.
42. Lyritis GP, Mayasis B, Tsakalakos N et al. The natural history of the osteoporotic vertebral fracture. Clin Rheumatol 1989;8 (Suppl. 2):66-69.
43. Grados F, Depriester C, Cayrolle G, Hardy N, Deramond H, Fardellone P. Long term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology 2000;39:1410-1414.
44. Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine 2000;25:923-928.
45. Cotten A, Boutry N, Cortet B et al. Percutaneous vertebroplasty: state of the art. Radiographics 1998;18:311-320.
46. Martin JB, Jean B, Sugiu K et al. Vertebroplasty: clinical experience and follow-up results. Bone 1999;25:11-15.
47. Kaufmann TJ, Jensen ME, Schweickert PA, Marx WF, Short JG, Kallmes DF. Age of fracture and clinical outcomes of percutaneous vertebroplasty. AJNR Am J Neuroradiol; 22:1860-1863.
48. Harrington KD. Major neurological complications following percutaneous vertebroplasty with polymethylmethacrylate: a case report. J Bone Joint Surg Am 2002;27:419-422.
49. Nussbaum DA, Gaillou P, Murphy K. A review of complications associated with vertebroplasty and kyphoplasty as reported to the Food and Drug Administration Medical Device Related Web Site. J Vasc Interv Radiol 2004;15:1185-1192.
50. Crandall D, Slaughter D, Hankins PJ, Moore C, Jerman J. Acute versus chronic vertebral compression fractures treated with kyphoplasty early results. Spine J 2004;4:418-424.
51. Majd ME, Farley S, Holt RT. Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures. Spine J 2005;5:244-255.
52. Gaitanis IN, Hadjipavlou AG, Katonis PG, Tzermiadianos MN, Pasku DS, Patwardhan AG. Balloon kyphoplasty for the treatment of pathological vertebral compressive fractures. Eur J Spine 2005.
53. Yaksh TI, Onofrio BM. Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain 1987;31:211-223.
54. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-467.
55. Paice JA, Penn RD, Scott S. Intraspinal morphine for chronic pain: a retrospective multicenter study. J Pain Symptom Manage 1996;11:71-80.
56. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment for chronic pain of non-malignant etiology: long-term benefits and efficacy. Surg Neurol 2001;55:79-88.
57. Njee TB, Irthum B, Roussel P, Peragut J-C. Intrathecal morphine infusion for chronic non-malignant pain: a multiple center retrospective survey. Neuromodulation 2004;7:249-259.
58. Krames ES, Lanning RM. Intrathecal infusional analgesia for non malignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993;8:539-548.
59. Brazenor GA. Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion of implanted pump. Neurosurgery 1987;21:484-491.
60. Saltuari L, Kronenberg J, Marosi MJ et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli) 1992;14:187-194.
61. Moulin DE, Leezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. A randomised trial of oral morphine for chronic noncancer pain. Lancet 1996;347:143-147.
62. World Health Organization. Cancer Pain Relief, 2nd ed. Geneva, Switzerland: World Organization, 1989.
63. Krames ES, Olson K. Clinical realities and economic considerations: patient selection in intrathecal therapy. J Pain Symptom Manage 1997 Sep;14 (Suppl. 3):S3-13.
64. Winkelmuller W, Burchiel K, Van Buyten J-P. Intrathecal opioid therapy for pain: efficacy and outcomes. Neuromodulation 1999;2:67-76.
65. Deer T, Winkelmuller W, Erdine S, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation 1999;2:55-66.
66. Raffaeli W, Andruccioli J, Righetti D, Caminiti A, Balestri M. Intraspinal therapy for the treatment of chronic pain: a review of the literature between 1990 and 2005 and suggested protocol for its rational and safe use. Neuromodulation 2006;9:290-308.
67. Ahmed SU, Martin NM, Chang Y. Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey. Neuromodulation 2005;8:112-120.
68. Vainnio A, Tigerstedt I. Opioid treatment for radiation cancer pain: oral administration vs. epidural techniques. Acta Anaesthesiol Scand 1988;32:179-185.
69. Njee TB, Irthum B, Roussel P et al. Intrathecal Morphine Infusion for Chronic Non-Malignant Pain: A Multiple Center Retrospective Survey. Neuromodulation 2004;7:249-259.
70. Mather LE. The clinical effects of morphine pharmacology. Reg Anaesth 1995;20:263-282.